Jennifer Natashsa David, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3518 Drawbridge Pkwy Ste 320, Greensboro, NC 27410 Phone: 336-890-2210 Fax: 336-890-2211 |
Mr. Bruce Phillip Mccoy, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 526 North Elam Avenue, Suite 201, Greensboro, NC 27403 Phone: 336-855-6131 Fax: 336-855-6132 |
Dena Diane Anderson, MPAS, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1587 Yanceyville St, Greensboro, NC 27405 Phone: 336-271-2777 Fax: 191-033-6273 |
Arthur C Gray, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1587 Yanceyville St, Greensboro, NC 27405 Phone: 336-271-2777 Fax: 336-273-1910 |
Drew Alexander Jones, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2704 Saint Jude St, Greensboro, NC 27405 Phone: 336-954-7546 Fax: 336-235-4018 |
Dr. David E. Tart, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5704 Hidden Orchard Dr, Greensboro, NC 27410 Phone: 336-404-3213 |
William Harrison Turner Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2704 Saint Jude St, Greensboro, NC 27405 Phone: 336-954-7546 Fax: 336-235-2624 |
News Archive
The study, led by Dr. Shiela Strauss, Associate Professor of Nursing and Co-Director of the Statistics and Data Management Core for NYU's Colleges of Dentistry and Nursing, examined data from 2,923 adult participants in the 2003-2004 National Health and Nutrition Examination Survey who had not been diagnosed with diabetes.
Americans will start the New Year with resolutions that are doomed to fail if they don't deal with the underlying issue of stress before they join a gym, start a diet or throw the cigarettes away. Research shows that stress negatively impacts our ability to lose weight, quit smoking and stick with a new healthy lifestyle change.
Brain Drain (ISBN: 0984196307; 978-0984196302) authored by Charles F. Glassman, M.D., FACP, is a powerful new book that teaches people how to break free of their brains' automatic responses through understanding and controlling their mind/body connections.
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).
The case of an Australian woman unable to open her eyes on three days of each week is confounding doctors.
› Verified 4 days ago